MEF2C and amyotrophic lateral sclerosis: Furthermore, decreased MEF2C immunoreactivity was observed by immunofluorescence staining in cortical pyramidal neurons of ALS patients and ALS mice model (SOD1-G93A) (Supplementary Fig. 2A, C).